✦ LIBER ✦

P119 Phase III study of lapatinib after completion of adjuvant chemotherapy in trastuzumab-naive women with ErbB2-overexpressing breast cancer: Tykerb evaluation after chemotherapy (TEACH) study

✍ Scribed by B. Moy; J.D. Maltzman; P.E. Goss

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

TEACH phase III study of lapatinib after

✍ B. Mov; J.D. Maltzman; E. Rappold; D. Finkelstein; L.S. Williams; R.E. Goss 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 71 KB

0154 TEACH: Phase III study of lapatinib

✍ B. Moy; J.D. Maltzman; E. Rappold; L. Nicolodi; L.S. Williams; P.E. Goss 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 54 KB

P301 Addition of pertuzumab (P) to trast

✍ L. Gianni; T. Pienkowski; Y.-H. Im; L. Roman; L.-M. Tseng; M.-C. Liu; A. Lluch-H 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 37 KB

32 ASTRRA study: a randomised phase III

✍ W.C. Noh; M.H. Hur; S.H. Ahn; Y. Jung; S.J. Lee; E.S. Lee; B.W. Park; J. Jong; S 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 63 KB